Jeanine Bortel, MPH
Jeanine Bortel, MPH, is currently an Executive Director at Pfizer based in New York City. She leads a group of Clinical Study Team Leads who are accountable for clinical trials from concept through approval in the Oncology portfolio focused on breast, prostate and bladder cancer.
Jeanine has been with Pfizer since January 2001 in various clinical operations leadership roles. She has supported a wide range of therapeutic areas including anti-infectives, internal medicine, oncology, inflammation & immunology, rare diseases and vaccines. In her previous roles she has led numerous programs, clinical trials and delivered over 50 major submissions driving revenue growth for Pfizer and accelerating availability of important medicines for patients.
In 2004, Jeanine was selected as a Pfizer Global Health fellow in Kampala, Uganda to work for the NGO, Health Volunteers Overseas.
She has over 27 years of clinical research experience providing strategic and performance driven leadership to successfully deliver global phase 1-IV clinical trials. She is a successful leader and line manager with a history of building and leading effective teams. Jeanine has expertise is leading large-scale process improvement initiatives and developing innovative solutions to optimize the drug development process.
Jeanine received her Bachelor of Science in Biology from Boston College in 1994 and her Master’s in Public Health in Socio medical Sciences from Columbia University in 1997.